Once curare was discovered it was evident to many physicians that it could have therapeutic implications, but the supply of the drug was scarce and the quality very unpredictable. Proper scientific evaluation was therefore very difficult for over a century.
This situation changed in the later part of the 1930s due largely to a tenacious man named Richard Gill. Richard Gill was born in 1901, the son of a physician, and he was expected to follow in his father's footsteps and study medicine. But after two years as an undergraduate he changed faculties and graduated with a Bachelor of Arts. He taught English for a while but had another change of heart and took a job as a salesman for a rubber company in South America. Together with his wife, Ruth, he embarked upon an adventure, settling in Ecuador and building a homestead in a remote part of the country. He befriended the local native tribes and studied their many customs and drugs, including curare. In 1932, just before a trip back to the U.S.A., he fell from his horse and developed a series of neurological symptoms which were later diagnosed as multiple sclerosis, a diagnosis he always rejected.
On return to the U.S.A. he deteriorated markedly until, by 1934, he was almost completely paralysed. During his protracted recovery he suffered from severe muscle spasms. His doctor, Walter Freeman, mentioned that such spasms might be treatable if only they could obtain sufficient quantities of curare. This was enough to motivate Gill's rehabilitation. Over the next four years he undertook intensive physiotherapy, gradually regaining use of his fingers and hands and learning to walk with crutches. Within two years he could drive again and by 1938 he was walking with a stick and ready to tackle another jungle adventure. Throughout those four years he spent time improving his knowledge of botany and pharmacology and also managed to obtain financial backing for his planned expedition from a wealthy businessman, Sayre Merrill.
A hundred years after Waterton's adventures, conditions in the jungle had not improved. Once back in Ecuador the Gills moved on from their homestead, establishing a remote base camp of bamboo huts where they learnt to "live in harmony" with the scorpions, tarantulas and ants. They waded through mud, travelled through rapids in canoes and blindfolded their mules to get them over slippery suspension bridges. But they achieved their objective, returning to the U.S.A. four months later with seventy-five botanical specimens, including twenty-five pounds of crude curare.
Via Gills' neurologist some research was undertaken with this curare by Professor Bennett, a professor of neurology in Nebraska, but he was only able to confirm earlier findings that the temporary improvement in spastic paralysis was never sustained. The bulk of the curare was given to Squibb, a pharmaceutical manufacturer. There H. A. Holaday devised a rabbit head-drop test that allowed them to produce a biologically standardized form of curare. They named this drug Intocostrin. Bennett continued his work with this drug and discovered that it was very successful in preventing fractures in electro-convulsive therapy, a relatively new treatment in psychiatry at the time. He published these findings in 1940; Squibb now had a marketable drug.
Dr Lewis Wright was a physician at Squibb who had trained originally as an anaesthetist. It was his job to market Intocostrin and he suggested its use in anaesthesia to Harold Griffith in Montreal. Griffith and his resident, Enid Johnson, administered Intocostrin successfully to twenty-five patients in 1942, publishing their results later that year. They used between 20 and 100 mg of curare and achieved relaxation within one minute that lasted for about fifteen minutes. The patients ranged in age from 18 to 70 years, the majority undergoing appendicectomies or other intraperitoneal operations. They all had cyclopropane anaesthesia which was deliberately lightened in many cases to cause muscle straining, thus allowing the curare to be fully evaluated.
It has not been necessary to administer artificial respiration or stimulants in any of our cases. As our patients are all under gas anaesthesia, with means of resuscitation by oxygen immediately available, we do not fear this complication. Since prostigmine is used as an antidote to curare, an ampule of this drug should always be available.
In many case they used the drug only at the end of the case to allow for peritoneal closure ... and within one minute the abdomen was "as soft as dough" and the surgeon was able to finish the operation without any difficulty.
At this stage it was still presumed that curare had a sedative effect and in 1945 Whitacre and Fisher gave Intocostrin without general anaesthesia to five patients. Two of these patients were given local anaesthetic at the site of the operation. The patients were then given curare until respiration ceased and consciousness was lost. They were maintained with artificial respiration. Some of these operations lasted over an hour and, needless to say, the patients were able to recount the pain of their operations on completion of the surgery. The problem of awareness with muscle relaxants was therefore demonstrated early in their history in a rather dramatic fashion.
Intocostrin was the first muscle relaxant used in Australia. Lewis Wright left Squibb to become Commander Wright of the United States Navy in the later part of World War II. He came to Sydney late in 1942 with a letter of introduction from Harold Griffith to Harry Daly and some ampoules of Intocostrin. Anaesthesia was still a new specialty in Australia at the time and it was three years before Harry Daly could try out this new drug due to resistance from his surgical colleagues. Eventually he was able to use it in 1945 for a dental surgeon, Frank Carberry, at St Vincent's Hospital in Sydney and both were delighted with the result.
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